Pure Global

BALVERSA 4 MG FILM COATED TABLET, 28 PCS - Turkey License d95f5aa3374f8bc1851ef8980ffc578b

Access comprehensive regulatory information for BALVERSA 4 MG FILM COATED TABLET, 28 PCS in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number d95f5aa3374f8bc1851ef8980ffc578b with license number 2022/597and contains active ingredient Erdafitinib . The license is held by JOHNSON AND JOHNSON SIHHİ MAL. SAN. VE TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
d95f5aa3374f8bc1851ef8980ffc578b
License Details
Turkey SFDA License: d95f5aa3374f8bc1851ef8980ffc578b
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

BALVERSA 4 MG FILM COATED TABLET, 28 PCS
TR: BALVERSA 4 MG FİLM KAPLI TABLET, 28 ADET
Pharmaceutical Product

License Details

d95f5aa3374f8bc1851ef8980ffc578b

2022/597

8699593095641

L01EN01

License Holder Information

Active Ingredient

Erdafitinib

License Information

Oct 17, 2022